Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Aripiprazole 10 mg Orally Disintegrating Tablets in Healthy Thai Volunteers Under Fasting
TCTR20230503001Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of aripiprazole (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
aripiprazole
Beyond the preview
Go deeper on TCTR20230503001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230503001.